Georges Gemayel has sold stock and made no open-market buys since Jul 2020
Director at Supernus Pharmaceuticals, Inc., and 1 other company
SEC CIK 0001256088 · Filings on SEC.gov ↗
$0Bought
$3.0MSold
NoneLast buy
Companies
Every filing
6 filings since Jul 2020, newest first
SUPNSell
Supernus Pharmaceuticals, Inc.
Director
$1.0M−41.0%Mar 9
SUPNSell
Supernus Pharmaceuticals, Inc.
Director
$392K−45.0%Nov 12
SUPNSell
Supernus Pharmaceuticals, Inc.
Director
$520K−52.0%Nov 8
SUPNSell
Supernus Pharmaceuticals, Inc.
Director
$435K−51.0%Sep 17
MNTASell
Momenta Pharmaceuticals Inc
Director
$330K−42.0%Aug 7
MNTASell
Momenta Pharmaceuticals Inc
Director
$300K−42.0%Jul 30
Filings come from SEC EDGAR. Not investment advice.